A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.2 GBX
Market Cap: 347m GBX

Intrinsic Value

The intrinsic value of one APH stock under the Base Case scenario is 101.71 GBX. Compared to the current market price of 64.2 GBX, Alliance Pharma PLC is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

APH Intrinsic Value
101.71 GBX
Undervaluation 37%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Alliance Pharma PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
APH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for APH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Alliance Pharma PLC
LSE:APH
UK
Pharmaceuticals
Market Cap
347m GBX
IPO
Nov 22, 2001
UK
Pharmaceuticals
Market Cap
347m GBX
IPO
Nov 22, 2001
Price
gbxfalse
EPS
ÂŁfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about APH?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Alliance Pharma PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alliance Pharma PLC

Current Assets 104.3m
Cash & Short-Term Investments 32.4m
Receivables 49.4m
Other Current Assets 22.6m
Non-Current Assets 264.8m
PP&E 5.4m
Intangibles 253.6m
Other Non-Current Assets 5.8m
Efficiency

Free Cash Flow Analysis
Alliance Pharma PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Alliance Pharma PLC

Revenue
178.8m GBP
Cost of Revenue
-69.6m GBP
Gross Profit
109.3m GBP
Operating Expenses
-75.9m GBP
Operating Income
33.4m GBP
Other Expenses
-44.2m GBP
Net Income
-10.7m GBP
Fundamental Scores

APH Profitability Score
Profitability Due Diligence

Alliance Pharma PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
ROIC is Increasing
49/100
Profitability
Score

Alliance Pharma PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

APH Solvency Score
Solvency Due Diligence

Alliance Pharma PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Average Altman Z-Score
49/100
Solvency
Score

Alliance Pharma PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APH Price Targets Summary
Alliance Pharma PLC

Wall Street analysts forecast APH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.

Lowest
Price Target
62.62 GBX
2% Downside
Average
Price Target
67.61 GBX
5% Upside
Highest
Price Target
89.25 GBX
39% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for APH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one APH stock?

The intrinsic value of one APH stock under the Base Case scenario is 101.71 GBX.

Is APH stock undervalued or overvalued?

Compared to the current market price of 64.2 GBX, Alliance Pharma PLC is Undervalued by 37%.

Back to Top